News
01-14-2015, 05:40 AM
Sophia Genetics, the European leader in Data Driven Medicine, has today obtained CE-IVD marking for its solution to detect BRCA1/2 associated genetic variants in live tumours.
More... (http://www.news-medical.net/news/20150114/Sophia-Genetics-obtains-CE-IVD-marking-for-BRCA12-testing-solution.aspx)
More... (http://www.news-medical.net/news/20150114/Sophia-Genetics-obtains-CE-IVD-marking-for-BRCA12-testing-solution.aspx)